| Zacks Company Profile for NutraLife Biosciences, Inc. (NLBS : OTC) |
|
|
| |
| • Company Description |
| NutraLife Biosciences Inc. operates a multifaceted life sciences company. It manufactures and distributes private label and branded nutraceutical and wellness products. The company, through its subsidiaries, Precision Analytic Testing, Inc. and PhytoChem Technologies Inc., provides bulk material analytical, identity, potency and purity testing of raw hemp, hemp cultivation, raw bulk material extraction and processing. NutraLife Biosciences Inc., formerly known as NutraFuels Inc., is based in FL, United States.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $ |
Daily Weekly Monthly
 |
| 20 Day Moving Average: shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: |
| 52 Week High: $0.00 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
% |
% |
| 12 Week |
% |
% |
| Year To Date |
% |
% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
6601 LYONS ROAD SUITE L-6
-
COCONUT CREEK,FL 33073
USA |
ph: 888-509-8901
fax: 954-775-0831 |
None |
http://www.nutralifebiosciences.com |
|
|
| |
| • General Corporate Information |
Officers
Edgar Ward - Chief Executive Officer; President; Director
Neil Catania - Vice President
- - -
- - -
- - -
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 67098B107
SIC: 2020
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: % |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
